Prevention of Future Deaths reports · 2019

Peter Carroll

Regulation 28 report to prevent future deaths, reference 2019-0162, written 11 Mar 2019. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report11 Mar 2019
Reference2019-0162
DeceasedPeter Carroll
CoronerJean Harkin
Coroner areaManchester City
CategoryHospital Death (Clinical Procedures and medical management) related deaths
Organisation namedManchester University NHS Foundation Trust
Sourcejudiciary.uk record · original PDF
Responses published1

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

REGULATION 28:  REPORT TO PREVENT FUTURE DEATHS. 

  REGULATION 28 REPORT TO PREVENT FUTURE DEATHS 

THIS REPORT IS BEING SENT TO: 

  Sir Michael Deegan, Chief Executive of MFT 

Copied for interest to: 
  Chief Coroner 
  Next of kin 

1  CORONER 

I am Ms Jean Harkin, Assistant Coroner, Manchester City Area 

2  CORONER’S LEGAL POWERS 

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 
2009 and regulations 28 and 29 of the Coroners (Investigations) Regulations 2013. 

3 

INQUEST 

I concluded the inquest into the death of Peter CARROLL on 5th October 2018 and 
recorded that he/she died from: 

1a   Peritonitis 
  b   Perforated caecal volvulus; operated on 
  c   Perianal squamous cell carcinoma requiring colostomy 
II     Coronary artery atheroma and pulmonary embolism and obesity 

4  CIRCUMSTANCES OF THE DEATH 

The deceased had a complex medical history. He had a chronic ulcer on the need to 
craft for over 30 years and this developed into malignancy diagnosed in early 2017. 

A biopsy was taken on 6th October 2016. This was not recorded on the deceased 
discharge notification form and it was not until the 20th April 2017, at the result of 
squamous cell carcinoma, was it seen by the treating consultant. 

Although the delayed biopsy reporting did not contribute to this death, if such delay 
continues, It could result in future fatalities. 

An Incident Investigation Report Level 2 Comprehensive was compiled and the 
investigation reviewed the following: 

1 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1.   The biopsy taken on 6th October 2016 was not recorded on the 

deceased’s discharge notes. Therefore, the treating consultant and administrative 
staff were unaware of the need to chase results or indeed the seriousness of the 
results. 

2.   The sample was wrongly labelled and as a result not reported to the 

multidisciplinary team warranting earlier action. 

Although certain measures have been implemented to try to prevent 
recurrence, I am not satisfied that this is sufficient. 

5  CORONER’S CONCERNS 

During the course of the inquest the evidence revealed matters giving rise to 
concern. In my opinion there is a risk that future deaths will occur unless action is 
taken. In the circumstances it is my statutory duty to report to you. 

The MATTERS OF CONCERN are as follows: 

I am concerned that there is no leading physician signing off these reports in addition 
to processing by input on it systems thus reducing the effectiveness of the reporting. 

I am concerned that a 6 month delay in reporting, on the evidence, meant that a 
curable treatment was not an option however if reported in a timely manner, would 
most likely have resulted in a favourable outcome. 

6  ACTION SHOULD BE TAKEN 

In my opinion action should be taken to prevent future deaths and I believe you and 
your organisation have the power to take such action.  

7  YOUR RESPONSE 

You are under a duty to respond to this report within 56 days of the date of this 
report, namely by Tuesday 7th May 2019. I, the coroner, may extend the period. 

Your response must contain details of action taken or proposed to be taken, setting 
out the timetable for action. Otherwise you must explain why no action is proposed. 

8  COPIES and PUBLICATION 

I have sent a copy of my report to the Chief Coroner and to Interested Persons. I 
have also sent it to organisations who may find it useful or of interest. 

I am also under a duty to send the Chief Coroner a copy of your response.  

2 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The Chief Coroner may publish either or both in a complete or redacted or summary 
form. He may send a copy of this report to any person who he believes may find it 
useful or of interest. You may make representations to me, the coroner, at the time of 
your response, about the release or the publication of your response by the Chief 
Coroner. 

9  DATE:                                            NAME OF CORONER: 

11th March 2019 

Signed: 

Ms Jean Harkin  
HM Assistant Coroner for    
Manchester City Area 

3

Responses

1 response published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from Manchester University NHS Trust (PDF)
Joint Group Medical Directors’ Office 
Trust Headquarters 
Room 215, Cobbett House 
Oxford Road 
M13 9WL 

Tel:  0161 701 0205 

Email:  t

09 May 2019 

Ms J Harkin 
HM Assistant Coroner 
HM Coroner’s Office – Manchester City Area 
Manchester City Coroners’ Office & Court 
Exchange Floor 
The Royal Exchange Building 
Cross Street 
Manchester M2 7EF 

Sent via email to:  coroners.office@manchester.gov.uk 

Dear Ms Harkin 

Re:  Mr Peter Carroll – Regulation 28: Prevention of Future Deaths 

Thank  you  for  highlighting  your  concerns  in  respect  of  this  case,  which  I  have  now  had  the 
opportunity  to  look  into.    The  response  required  from  Manchester  University  NHS  Foundation 
Trust is in relation to the following: 

  no leading physician signing off reports 
  concerns re 6 month delay in reporting 

With regard to the responsible physicians signing off Histopathology reports; since this incident, 
processes in both Histopathology and the Department of Surgery have been strengthened. 

In  the  Department  of  Histopathology,  measures  have  been  instituted  such  that  in  the  event  of 
apparently  unexpected  or  metastatic  malignancy  in  a  specimen  from  a  site  outside  the 
pathologist’s area of expertise, that case is  redirected to another pathologist who specialises in 
that field.  All confirmed cancer cases are listed for discussion at relevant multidisciplinary team 
meetings  (MDTs).    In  the  case  of  delay  or  inability  to  discuss  in  the  appropriate  MDT, 
pathologists/pathology administrative staff have been instructed to email the report directly to the 
responsible  clinician.    In  addition,  a  printed  report  marked  ‘Urgent  Report’  will  be  sent  to  the 
responsible clinician. 

The  Royal  College  of  Pathologists  issued  guidance  in  October  2017  in  relation  to  the 
communication  of  critical  and  unexpected  pathology  results  (Document  G  158  –  which  is  the 
Royal  College  of  Pathology  document  number  that  describes  the  process  when  there  is 
unexpected pathology – enclosed as attachment). 

MFT Pathology team have confirmed that the process for managing pathology results has been 
updated  following  this  investigation  and  in  line  with  the  guidance  that  all  histology  samples 
confirming cancer diagnosis are directed to the appropriate cancer MDT. 

Within General Surgery, as part of the actions relating to this investigation, the team undertook a 
review of the administration processes in relation to histopathology paper results.  The provision 
of paper results currently provides a backup assurance system to the electronic process.  It was 
confirmed  by  the  Administration  Manager  on  27  April  2017,  that  as  part  of  this  review  into  Mr 
Carroll’s case, all histology paper results are now date stamped upon arrival into the department 

 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 and added to a tracker.  An outcome form is then attached to the histology result that requires 
the  requesting  consultant  to  review,  action  and  sign  off  with  immediate  effect  and  this  is  then 
updated  on  the  tracker.    The  administration  team  monitor  the  tracker  on  a  monthly  basis  to 
ensure the outcome is completed. 

A summary of the investigation and the learning was shared formally across the Division at the 
Surgery Clinical Effectiveness Group meeting on 20 April 2018 to ensure that all surgical teams 
had effective processes in place to deal with similar histopathology reports. 

The  investigation  also  found  that  another  factor  in  this  incident  was  that  the  Discharge 
Notification  Form  (DNF)  did  not  report  that  a  biopsy  had  been  taken.    Whilst  Mr  Carroll’s 
operation  note  was  available  electronically  to  view  on  the  theatre  ORMIS  electronic  record 
system in October 2016, at that time it was necessary for clinicians to undertake a separate log-
in  to  access  operation  notes  when  DNFs  were  being  completed.    This  process  has  been 
strengthened  from  April  2017.    MFT  Chameleon  Electronic  Patient  Record  (EPR)  system 
improvements  have  facilitated  the  inclusion  of  operation  notes  thus  creating a  single  electronic 
record  source  to  access  operation  notes  when  DNFs  are  being  completed  hence  reducing  the 
possibility of similar omissions, due to the need to refer to multiple sources of information. 

A  further  plan  to  improve  communication  of  test  results  is  currently  being  implemented  at  our 
Oxford Road site.  At the Wythenshawe site of MFT, we introduced a fully  electronic paperless 
system  of  reporting  test  results  to  requesting  clinicians,  which  facilitates  electronic  results 
acknowledgement  and  allows  tracking  of  clinician  performance  in  reviewing  results.    We  are 
currently introducing a similar system within the Chameleon EPR at Oxford Road site. 

The  investigation  outcome  concluded  that  it  was  not  possible  to  ascertain  with  any  certainty 
whether the 6 month delay in reviewing Mr Carroll’s biopsy results impacted negatively upon his 
treatment  plan,  or  indeed  influenced  his  prognosis.    However,  we  sincerely  apologise  to  Mr 
Carroll’s family for this delay and any additional distress arising from it. 

Please  accept  my  assurances  that  lessons  have  been  learned  from  this  case  and  appropriate 
actions have been put in place to address the issues raised.  If you require anything further then 
please do not hesitate to contact me. 

Yours sincerely 

Joint Group Medical Director 

Encl. 

www.mft.nhs.uk 

Incorporating: 
Altrincham Hospital • Manchester Royal Eye Hospital • Manchester Royal Infirmary • Royal Manchester Children’s Hospital •  
Saint Mary’s Hospital • Trafford General Hospital • University Dental Hospital of Manchester • Wythenshawe Hospital •  
Withington Community Hospital • Community Services

Related reports

Other reports by Jean Harkin

See all →

More reports categorised “Hospital Death (Clinical Procedures and medical management) related deaths”

See all →

Track Manchester University NHS Foundation Trust

See every Prevention of Future Deaths report matching Manchester University NHS Foundation Trust, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.